Clinical Guidance
Managing GLP-1 Side Effects: What Helps, What Is Normal, What Is Not
Nausea, constipation, fatigue, sulfur burps, and their companions are the toll the incretin class charges, mostly during dose increases, mostly manageable with strategy rather than heroics. What clinicians actually suggest for each, which symptoms mean call the physician today, and why quitting during a side effect wave is usually quitting at the worst possible moment.
Reviewed by board-certified physicians · Published 2026-08-28 · Updated 2026-08-28 · 10 min read
Key facts
- Gastrointestinal effects are the class signature: nausea, constipation, diarrhea, and vomiting led every GLP-1 trial's side effect table.
- Effects cluster around dose increases and ease with adaptation for most people; persistent severity is the exception worth escalating.
- Food strategy, portion size, fat load, eating speed, does more for nausea than any single remedy.
- Constipation responds to fluid, fiber, and movement first; stimulant reliance is a physician conversation.
- Temporary hair shedding after substantial weight loss is a recognized phenomenon (telogen effluvium) tied to rapid loss itself, not a direct drug effect.
- Severe abdominal pain, repeated vomiting, dehydration signs, and right-upper-belly pain are same-day medical calls, not forum threads.
Nausea: the headline act, and the strategies that actually help
Nausea tops every trial table in this class, concentrated after dose increases and typically fading as each rung settles. The mechanism is the medicine doing its job, slowed stomach emptying and altered appetite signaling, which is exactly why the countermeasures are food-mechanical: smaller portions, eaten slowly, stopping at the first fullness signal rather than the last; lower-fat and less aromatic meals during the sensitive days; cold or bland options when cooking smells turn hostile; and not lying down soon after eating. Ginger and peppermint have modest supportive evidence and enthusiastic anecdote; carbonated water helps some.
When strategy is not enough, say so at follow-up rather than enduring: prescribers can slow the titration, hold a dose, or add short-term anti-nausea medication. The one move with no defense is pushing to the next dose increase on schedule while barely tolerating the current one.
Constipation and its opposite: the unglamorous middle of the story
Slower gut transit plus smaller food volume plus less fluid intake is the constipation recipe, and all three levers reverse it: deliberate hydration, since suppressed appetite quietly suppresses drinking too; fiber from food or a psyllium-type supplement, added gradually; and daily movement, which is gut motility's oldest ally. Over-the-counter softeners and osmotic options are commonly used next steps that are still worth naming to your physician, particularly before anything stimulant becomes a habit.
Diarrhea visits some people instead, usually early and usually transient; the management is hydration, blandness, and patience, with persistence or alternation between extremes worth reporting. Sulfur burps, the class's strangest calling card, track slowed digestion; smaller meals, less fat, and not eating close to bedtime blunt them for most.
Fatigue, dizziness, and the calorie arithmetic behind them
Tiredness in the early months is common and usually overdetermined: the body is adapting to the medication, running on fewer calories than it has seen in years, and sometimes under-hydrated on top. The checklist runs: eating enough overall, protein especially, per our protein guide; fluids and electrolytes, particularly around exercise; sleep, which appetite change sometimes disrupts before it settles; and pacing rather than abandoning activity, since movement generally improves the energy story over weeks.
Dizziness on standing deserves its own note: it often signals fluid or food intake running too low, and if you take blood pressure or diabetes medication, weight loss can change what doses you need, a physician conversation that should happen proactively rather than after a near-faint.